Article: Safety First
On 5 November 2018, the current EU GDP Guideline turned five years old. What have we learned in those five years? Have we succeeded in achieving a better protection of the integrity of pharmaceutical products and fortified patient safety? What did it mean for the R&D industry, the drug manufacturers and their service partners in the supply chain?
Executive Summary: Logistics by Design - a Framework for Advanced Therapy Developers to Create Optimal Logistics Platforms
Logistics by Design (LbD) is a framework for logistics decision making. Using a risk based analysis it identifies the areas within the supply chain that need to be addressed to create a logistics platform that can meet the needs of patients at clinical and commercial scale.
Article: The Cost of Failure Part 2: The Patient
Article: The Cost of Failure Part 1: Too High a Price
To truly understand the distribution challenges faced by today’s pharmaceutical industry in bringing a new product to the clinical or commercial market, this four-part blog series will explore the most impacted areas of the supply chain following a temperature excursion, starting with financial costs to the clinical sponsor.
Video: Logistics Leaders: The Real Cost of Quality
Logistics Leaders: How is World Courier Harnessing Emerging Technology for Customer Benefit?
Executive Summary: How to Reduce the Risks Created by Next Gen Biologics
Article: GDP Consideration: Now a Requirement When Shipping IMP
There is now a clearer vision for how IMP should be handled. Find out how the updated GDP guidelines bring clarity and accountability to IMP shipments.
Video: Logistics Leaders: Project Nova - World Courier's Transformation Program
Learn how World Courier's multi-year business transformation program (NOVA) will bring service enhancements and efficiencies to customers.
White Paper: The Cost of Quality in the Specialty Pharmaceutical Supply Chain
Video: Logistics Leaders: Being Ahead of Regulatory Challenges
Rudiger Lomb, Vice President, Global Quality and Technical Compliance at World Courier, discusses the current regulatory challenges that are impacting the specialty logistics industry.
Video: Logistics Leaders: IMP Storage Closing the Accountability Gap.
Article: GDP - The Critical Link in Maintaining Quality from GMP to the Patient
Video: Creating Value Through Customer Service Excellence
At World Courier, customer service is at the heart of our company. Watch Mattias Mineur, Sub-Regional Director Nordics, explain how World Courier provides an industry leading service and why we treat every shipment as if it was our own.
Video: Logistic Leaders - Why is Global GDP Certification Important for the Logistics Industry?
Learn why global GDP certification is important for the logistics industry and how World Courier goes beyond this framework.
White paper: How to mitigate risk and create competitive advantage with a new model of pharmaceutical logistics
Find out how to create competitive advantage by developing a fit-for-purpose supply chain that supports the market’s paradigm shift.
Video: Logistics Leaders - What is the Importance of Compliance for a Specialist Logistics Provider
Article: Six Steps for Reducing the Risks of Temperature Excursion
This article discusses the key to avoiding temperature excursions and then planning for the most common challenges.
Article: Beyond Compliance to Excellence
Webinar on-demand: Ensuring Regulatory Compliance and Quality in Direct-to-Patient Clinical Trials
In this webinar, World Courier and Medical Research Network guide participants through the key regulatory considerations when planning direct to patient trials.
White paper: Modern Risk Management in Global Pharmaceutical Logistics
An overview of the risks inherent to global pharmaceutical logistics and the associated risk management. Get your white paper now.
Article: Dangerous Goods Changes for 2017
Significant changes have been made in 2017, we've listed out all the changes that you need to be aware of based on the 58th edition first print of the DGR IATA book
Article: What Do You Need to Know to Ensure Shipping Success to North Africa?
Podcast: The X in GxP Compliance
A panel of experts discuss what it takes to be fully GxP compliant and what that means to manufacturers
Infographic: A Guide to Packaging Evaluation
Top considerations for selecting the right packaging
Video: Logistics Leaders - How Smart Technology Can Lead to Advanced Quality
Ruediger Lomb, Vice President, Global Quality and Technical Compliance, AmerisourceBergen Specialty Group, shares the benefits and considerations of developing smart technology.
Video: Logistics Leaders: Should Clinical Trials Embrace Procurement Teams?
How are procurement teams changing the clinical trial landscape for the better?
Video: Logistics Leaders - GxP Value in Specialty Logistics
Article: World in Motion
Discover why there is a demand for more targeted logistics solutions, particularly in the clinical trials arena.
Article: What Can Green Do for You?
How sustainability efforts change your supply chain for the better...
Infographic: Owned vs Agent
Counterfeit drugs remain a supply chain risk in emerging markets
Article: Reducing Risk With a Global Code of Ethics
What you need to know to ensure integrity
Webinar on-demand: Efficient Implementation of a Global Code of Ethics
Corruption can be a huge hurdle when it comes to global expansion. Are you ensuring best business conduct across the globe?
Article: Thailand — Prepare for Success
Thailand is becoming more like other, more developed markets in the region, and as part of the ASEAN region, it offers excellent opportunities. Growth is expected in both clinical and commercial prospects.
Video: Logistic Leaders - How World Courier Stays Ahead of Regulatory Challenges
Ruediger Lomb, Vice President, Global Quality and Technical Compliance at World Courier, discusses the current regulatory challenges that are impacting the specialty logistics industry.
White paper: Securing the Global Pharmaceutical Supply Chain against the Threat of Counterfeit Drugs
Learn how to protect your supply chain against counterfeit drugs with our white paper